rian.ie - Results

A A A

Current Search:	'Cancer' in all fields;

Displaying Results 76 - 100 of 3156 on page 4 of 127

Mark

An examination of the pharmacology of HER2 inhibitor responses in cellular models of breast cancer (2014)

O'Neill, Fiona

Mark

Cancer projections for Ireland 2015-2040 (2014)

National Cancer Registry

Mark

'Pragmatic randomized controlled trial of individually prescribed exercise versus usual care in a heterogeneous cancer survivor population': a feasibility study PEACH trial: prescribed exercise after chemotherapy. (2010)

WALSH, JULIE; HUSSEY, JULIETTE; GUINAN, EMER; O'DONNELL, DEARBHAILE

Mark

Melanoma-associated antigen family protein-D4: clinical significance and functional relevance in breast cancer (2010)

O'Driscoll, Lorraine

Mark

Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery. (2010)

PIDGEON, GRAHAM; REYNOLDS, JOHN; MAHER, STEPHEN; WHITE, BARRY; O'DONNELL, JAMES

Mark

Trends and Patterns in Cancer Mortality in Northern Ireland (2010)

Donnelly, D.W.; Gavin, A.T.

Mark

Platelet Adhesion and Degranulation Induce Pro-Survival and Pro-Angiogenic Signalling in Ovarian Cancer Cells (2011)

SMYTH, PAUL; O'LEARY, JOHN; O'TOOLE, SHARON; SPILLANE, CATHY; MARTIN, CARA; G...

Platelet Adhesion and Degranulation Induce Pro-Survival and Pro-Angiogenic Signalling in Ovarian Cancer Cells (2011)

SMYTH, PAUL; O'LEARY, JOHN; O'TOOLE, SHARON; SPILLANE, CATHY; MARTIN, CARA; GALLAGHER, MICHAEL; NORRIS, LUCY; CONLON, NIAMH; MCEVOY, LYNDA MARIE; FFRENCH, GEORGE BRENDAN; STORDAL, BRITTA; KEEGAN, HELEN; FINN, STEPHEN; MCENEANEY, VICTORIA; SHEILS, ORLA; CROWLEY, DARRAGH

Abstract:

Thrombosis is common in ovarian cancer. However, the interaction of platelets with ovarian cancer cells has not been critically examined. To address this, we investigated platelet interactions in a range of ovarian cancer cell lines with different metastatic potentials [HIO-80, 59M, SK-OV-3, A2780, A2780cis]. Platelets adhered to ovarian cancer cells with the most significant adhesion to the 59M cell line. Ovarian cancer cells induced platelet activation [P-selectin expression] in a dose dependent manner, with the most significant activation seen in response to the 59M cell line. The platelet antagonists [cangrelor, MRS2179, and apyrase] inhibited 59M cell induced activation suggesting a P2Y12 and P2Y1 receptor mediated mechanism of platelet activation dependent on the release of ADP by 59M cells. A2780 and 59M cells potentiated PAR-1, PAR-4, and TxA2 receptor mediated platelet activation, but had no effect on ADP, epinephrine, or collagen induced activation. Analysis of gene expres...